|
Research Management and Support
|
RMS ES 2016
|
$320,501,735
|
$202,000
|
N/A
|
National Institutes of Health
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-03S1
|
$3,025,319
|
$3,025,319
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Solid Malignancy Integrated Translational Science Center
|
5U10CA180884-03
|
$400,000
|
$400,000
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-03
|
$21,084,883
|
$21,084,883
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Mapping cancer micro-environments for acute leukemia
|
1R01CA202025-01A1
|
$463,557
|
$231,779
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Oncohistones: Role of Histone H3 Mutations in the Oncogenesis of Pediatric Cancers
|
3P01CA196539-01S1
|
$34,299
|
$34,299
|
ALLIS, CHARLES
|
ROCKEFELLER UNIVERSITY
|
|
Oncohistones: Role of Histone H3 Mutations in the Oncogenesis of Pediatric Cancers
|
5P01CA196539-02
|
$1,855,117
|
$630,740
|
ALLIS, CHARLES
|
ROCKEFELLER UNIVERSITY
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144-07130
|
$1,939,406
|
$1,939,406
|
Alter, Blanche
|
DCEG (NCI)
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-47S1
|
$142,498
|
$2,850
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-47
|
$2,645,581
|
$52,912
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$791,464
|
$39,573
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
The role of ATRX and H3.3 mutations in pediatric glioblastoma
|
5F32CA189741-03
|
$57,002
|
$57,002
|
ANASTAS, JAMIE
|
CHILDREN'S HOSPITAL CORPORATION
|
|
General Descriptive Studies
|
ZIA CP010183-00350
|
$106,509
|
$10,651
|
Anderson, William
|
DCEG (NCI)
|
|
Collaborative Pathways that Lead to Leukemia
|
ZIA BC 010982
|
$450,906
|
$450,906
|
Aplan, Peter
|
CCR (NCI)
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIA SC 010378
|
$322,076
|
$161,038
|
Aplan, Peter
|
CCR (NCI)
|
|
Mechanisms of Chromosomal Translocation
|
ZIA SC 010379
|
$128,830
|
$51,532
|
Aplan, Peter
|
CCR (NCI)
|
|
Reducing risk of Anthracycline-related heart failure after childhood cancer
|
5R01CA196854-02
|
$669,859
|
$669,859
|
ARMENIAN, SARO
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Longitudinal Cardiotoxicity in Adult Survivors Childhood Cancer
|
4R01CA157838-05
|
$536,801
|
$536,801
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Childhood Cancer Survivor Study
|
4U24CA055727-22
|
$4,172,004
|
$3,754,804
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Targeting to Epigenetic Modications in ALL
|
7R01CA176745-06
|
$402,250
|
$402,250
|
ARMSTRONG, SCOTT
|
DANA-FARBER CANCER INST
|
|
Significance of Marrow Karyotypes in Inherited Bone Marrow Failure Syndromes
|
ZIA BC 010692
|
$35,443
|
$7,089
|
Arthur, Diane
|
CCR (NCI)
|
|
Clinical Cancer Cytogenetics
|
ZID BC 010694
|
$602,530
|
$120,506
|
Arthur, Diane
|
CCR (NCI)
|
|
Molecular Diagnostics for Risk Stratification and Monitoring of Neuroblastoma
|
5R01CA182633-03
|
$665,155
|
$665,155
|
ASGHARZADEH, SHAHAB
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Cancer Center Support Grant
|
3P30CA082103-18S1
|
$121,856
|
$15,841
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S2
|
$155,534
|
$20,219
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S3
|
$60,000
|
$7,800
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S4
|
$80,100
|
$10,413
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S5
|
$200,000
|
$26,000
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S6
|
$152,100
|
$19,773
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S7
|
$200,000
|
$26,000
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S8
|
$749,207
|
$97,397
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
4P30CA082103-18
|
$7,063,742
|
$918,286
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Puerto Rico NCI Community Oncology Research Program Minority/Underserved
|
5UG1CA189862-03
|
$609,407
|
$60,941
|
BAEZ, LUIS
|
COMPREHENSIVE CANCER CENTER/ UNIV/PR
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-42S1
|
$125,000
|
$1,250
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
4P30CA014520-42
|
$4,288,496
|
$42,885
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Bay Area Tumor Institute NCORP
|
5UG1CA189817-03
|
$730,000
|
$182,500
|
BAILEY, LISA
|
BAY AREA TUMOR INSTITUTE
|
|
SARC Sarcoma SPORE
|
3U54CA168512-05S1
|
$47,692
|
$5,246
|
BAKER, LAURENCE
|
SARC
|
|
SARC Sarcoma SPORE
|
4U54CA168512-05
|
$2,161,999
|
$237,820
|
BAKER, LAURENCE
|
SARC
|
|
Normal and Neoplastic Growth in the Brain
|
5P01CA096832-12
|
$2,072,072
|
$2,072,072
|
BAKER, SUZANNE
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Tyrosine kinase inhibitors for the treatment of childhood AML
|
5R01CA138744-07
|
$343,388
|
$343,388
|
BAKER, SHARYN
|
OHIO STATE UNIVERSITY
|
|
Cooperating Pathways in Gliomagenesis
|
5R01CA188516-03
|
$372,203
|
$372,203
|
BAKER, SUZANNE
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Characterizing the resistance mechanisms to BET-bromodomain inhibition in MYC-amplified medulloblastoma
|
1K99CA201592-01A1
|
$151,039
|
$151,039
|
BANDOPADHAYAY, PRATITI
|
DANA-FARBER CANCER INST
|
|
Second generation MIBG analogs that cotarget DNA for high risk neuroblastoma
|
1R21CA187548-01A1
|
$196,403
|
$196,403
|
BARANOWSKA-KORTYLEWICZ, JANINA
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Studies of amplification in rhabdomyosarcoma
|
ZIA BC 011378
|
$202,987
|
$202,987
|
Barr, Frederic
|
CCR (NCI)
|
|
Studies of gene fusions in rhabdomyosarcoma
|
ZIA BC 011387
|
$405,974
|
$405,974
|
Barr, Frederic
|
CCR (NCI)
|
|
Epigenetic studies in rhabdomyosarcoma
|
ZIA BC 011423
|
$405,974
|
$405,974
|
Barr, Frederic
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,014,935
|
$101,494
|
Barr, Frederic
|
CCR (NCI)
|
|
Training Program in Nervous System Tumors
|
2K12CA090354-16
|
$805,200
|
$402,600
|
BATCHELOR, TRACY
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119-02020
|
$559,517
|
$55,952
|
Beane Freeman, Laura
|
DCEG (NCI)
|
|
Functional Dissection of the K27M Histone Mutation In Gliomagenesis
|
1R01CA197313-01A1
|
$363,713
|
$363,713
|
BECHER, OREN
|
DUKE UNIVERSITY
|
Total relevant funding to Childhood Cancers for this search: $206,767,589
|